抗凝或抗血小板药物患者针灸后出血相关不良事件的前瞻性观察研究
该前瞻性观察研究纳入428例接受针灸的住院患者,其中169例使用抗凝或抗血小板药物(暴露组),259例未使用(非暴露组)。暴露组与非暴露组出血相关轻度不良事件发生率分别为38.5%与44.4%,按治疗次数(RR 0.87,95%CI 0.69-1.10)和按针数(RR 0.89,95%CI 0.70-1.13)分析均无组间差异。结论提示抗凝和抗血小板药物不增加针灸后出血相关不良事件的发生率。
要点
- 使用抗凝或抗血小板药物的患者针灸后出血相关不良事件风险未显著增加。
- 多因素分析中仅针具粗细增加出血风险。
- 各进针部位亚组分析均未见用药增加出血风险。
核心结论
- 抗凝和抗血小板药物不增加针灸治疗后出血相关不良事件的发生率。
研究设计与样本
- 前瞻性观察研究,共纳入428例接受针灸治疗的住院患者。
- 暴露组169例使用抗凝或抗血小板药物,非暴露组259例未使用。
- 在第1天针灸后立即和第2天针灸前进行两次出血相关不良事件评估。
主要发现
- 按治疗次数分析,两组出血相关不良事件风险无差异(RR 0.87,95%CI 0.69-1.10)。
- 按针数分析,两组出血相关不良事件风险无差异(RR 0.89,95%CI 0.70-1.13)。
- 多因素分析中仅针具粗细增加出血风险。
- 亚组分析显示用药未增加任何进针区域的出血风险。
临床怎么用
- 对使用抗凝或抗血小板药物的患者,针灸治疗前无需因出血风险而常规回避。
- 临床操作中可关注针具粗细对出血风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the risk of bleeding-related adverse events after acupuncture treatment in patients receiving anticoagulant or antiplatelet drugs. DESIGN AND SETTING: A total of 428 inpatients who received acupuncture treatment underwent two assessments for bleeding-related adverse events, such as micro-bleeding, hematoma, and ecchymosis: 1) immediately after acupuncture treatment on the first day and 2) before acupuncture treatment on the following day. Additional analyses were performed using the number of acupuncture needles as independent variables. Multivariable analysis using factors likely related to bleeding and subgroup analysis according to regions of needle insertion were also performed. RESULTS: A total of 169 patients receiving anticoagulant or antiplatelet drugs (exposure group) and 259 patients not receiving either drug (non-exposure group) were studied. Sixty-five (38.5%) patients in the exposure group and 115 (44.4%) patients in the non-exposure group had bleeding-related mild adverse events. There was no difference in the risk of bleeding-related adverse events between the two groups per sessions (relative risk (RR) 0.87, 95% confidence interval (CI), 0.69-1.10) and per needles (RR 0.89, 95% CI 0.70-1.13). In multivariable analysis, thickness of needle only increased risk of bleeding. Subgroup analysis showed that taking these drugs did not increase the risk of bleeding in any of the regions. CONCLUSION: Our findings suggest that anticoagulant and antiplatelet drugs do not increase the incidence of bleeding-related adverse events after acupuncture treatment.
引用
- Lee M, Lee S, Kim E, et al. Evaluation of bleeding-related adverse events following acupuncture treatment in patients on anticoagulant or antiplatelet drugs: A prospective observational study. Complement Ther Med. 2018. PMID: 30477845. doi:10.1016/j.ctim.2018.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。